Clinical Cancer Research The Science of Cancer Health Disparities Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Utting, M.
Right arrow Articles by Junker, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Utting, M.
Right arrow Articles by Junker, K.
Clinical Cancer Research Vol. 8, 35-40, January 2002
© 2002 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Microsatellite Analysis of Free Tumor DNA in Urine, Serum, and Plasma of Patients

A Minimally Invasive Method for the Detection of Bladder Cancer

Michael Utting1, Wolfram Werner, Regine Dahse, Jörg Schubert and Kerstin Junker

Department of Urology [M. U., W. W., J. S., K. J.] and Institute of Human Genetics and Anthropology [R. D.], Friedrich-Schiller-University Jena, 07743 Jena, Germany

Purpose: Tumor cells may release DNA into circulation, which is subsequently carried as free DNA and enriched in blood and urine. The detection of tumors by microsatellite analysis of free DNA offers a possibility to establish a minimally invasive method for the detection of bladder cancer.

Experimental Design: We performed microsatellite analysis of free DNA of urine, serum, and plasma in comparison with DNA of lymphocytes and tumors of 40 patients with conspicuous bladder lesions. Six microsatellite markers were used for the detection of alterations on chromosomes 4, 9, and 17.

Results: Twenty-six of 36 bladder tumor tissue samples showed alterations. Microsatellite changes matching those in the tumor tissues were detected in at least one of the body fluids in 23 cases.

Conclusions: The study indicates that simultaneous and multiple investigations of microsatellite markers on free DNA of urine and blood could have clinical relevance as a minimally invasive method for diagnosis and screening of bladder cancer.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
R. Hanley, K. M. Rieger-Christ, D. Canes, N. R. Emara, A. P. Shuber, K. A. Boynton, J. A. Libertino, and I. C. Summerhayes
DNA Integrity Assay: A Plasma-Based Screening Tool for the Detection of Prostate Cancer
Clin. Cancer Res., August 1, 2006; 12(15): 4569 - 4574.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. Locke, Z. Kote-Jarai, E. Bancroft, S. Bullock, S. Jugurnauth, P. Osin, A. Nerurkar, L. Izatt, G. Pichert, G. P. H. Gui, et al.
Loss of Heterozygosity at the BRCA1 and BRCA2 Loci Detected in Ductal Lavage Fluid from BRCA Gene Mutation Carriers and Controls.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1399 - 1402.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
M. Woenckhaus, U. Grepmeier, B. Werner, C. Schulz, F. Rockmann, P. J. Wild, G. Rockelein, H. Blaszyk, M. Schuierer, F. Hofstaedter, et al.
Microsatellite Analysis of Pleural Supernatants Could Increase Sensitivity of Pleural Fluid Cytology
J. Mol. Diagn., October 1, 2005; 7(4): 517 - 524.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
Y.-H. Su, M. Wang, D. E. Brenner, A. Ng, H. Melkonyan, S. Umansky, S. Syngal, and T. M. Block
Human Urine Contains Small, 150 to 250 Nucleotide-Sized, Soluble DNA Derived from the Circulation and May Be Useful in the Detection of Colorectal Cancer
J. Mol. Diagn., May 1, 2004; 6(2): 101 - 107.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. El-Hefnawy, S. Raja, L. Kelly, W. L. Bigbee, J. M. Kirkwood, J. D. Luketich, and T. E. Godfrey
Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics
Clin. Chem., March 1, 2004; 50(3): 564 - 573.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. von Knobloch, H. Brandt, A. J. Schrader, A. Heidenreich, and R. Hofmann
Molecular Serological Detection of DNA Alterations in Transitional Cell Carcinoma Is Highly Sensitive and Stage Independent
Clin. Cancer Res., February 1, 2004; 10(3): 988 - 993.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. F. Eisenberger, W. T. Knoefel, M. Peiper, P. Merkert, E. F. Yekebas, P. Scheunemann, K. Steffani, N. H. Stoecklein, S. B. Hosch, and J. R. Izbicki
Squamous Cell Carcinoma of the Esophagus Can Be Detected by Microsatellite Analysis in Tumor and Serum
Clin. Cancer Res., September 15, 2003; 9(11): 4178 - 4183.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.